VIMTA LABS
Back to Income Statement
|
VIMTA LABS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹318 Cr | ₹318 Cr | ₹278 Cr | ₹211 Cr | ₹181 Cr |
What is the latest Revenue of VIMTA LABS ?
Year | Revenue |
---|---|
Mar2024 | ₹318 Cr |
Mar2023 | ₹318 Cr |
Mar2022 | ₹278 Cr |
Mar2021 | ₹211 Cr |
Mar2020 | ₹181 Cr |
How is Revenue of VIMTA LABS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹318 Cr | 0.02 | |
Mar2023 | ₹318 Cr | 14.34 | |
Mar2022 | ₹278 Cr | 32.09 | |
Mar2021 | ₹211 Cr | 16.58 | |
Mar2020 | ₹181 Cr | - |
Compare Revenue of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,334.9 Cr | 13.4% | 10.1% | 96.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 13.4% |
10.1% |
96.9% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses